Pipeline Preview (October 2006)

News
Article

Dalteparin (Fragmin, Pfizer) for the extended treatment of symptomatic venous thromboembolism (proximal deep vein thrombosis and/or pulmonary embolus) to prevent recurrent venous thromboembolism in patients with cancer

Recommendations for approval

Recommendations against approval

Nonapprovable designations

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.